About Trigenesis Therapeutics
Trigenesis Therapeutics is a Healthcare company based in Philadelphia (United States) founded in 2003, and was acquired by Dr. Reddy's Laboratories in May 2004. Proprietary drug delivery platforms are developed for dermatology drugs. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified. Its competitors include Avidity Biosciences, Revance Therapeutics and Sutro Biopharma; 3 of its 3 listed competitors have raised funding.
Company details
Trigenesis Therapeutics was established in 2003 in Philadelphia, United States, focusing on the pharmaceutical sector. Products for dermatology applications are created through proprietary drug delivery technology platforms. A pipeline of specialized drugs in the dermatology field is advanced by the firm. Operations emphasize innovation in therapeutic delivery methods. The entity was acquired by Dr. Reddys Laboratories in May 2004.
- Headquarters Philadelphia, United States
- Stage Acquired
- SectorsHealthcare
- Website trigenesistx.com
- Social LinkedIn
- Acquired by Dr. Reddy's Laboratories (May 2004)
- Investors
- Acquired byDr. Reddy's Laboratories
(May 2004)
Investors in Trigenesis Therapeutics
Trigenesis Therapeutics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Dr. Reddy's Laboratories.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Innovative medicines are developed and manufactured globally by the company. | 1984 | drreddys.com | Hyderabad, India |
Investor details for Trigenesis Therapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Trigenesis Therapeutics
2 dated milestones of Trigenesis Therapeutics across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Trigenesis Therapeutics is founded.
- Exit Acquired by Dr. Reddy's Laboratories.
Competitors of Trigenesis Therapeutics
Trigenesis Therapeutics has 3 listed competitors in our database, 3 of them funded. They include Avidity Biosciences, Revance Therapeutics and Sutro Biopharma.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| revance.com | 2002 | Newark, United States | $154.56M | 597 | Neurotoxin products for aesthetic and therapeutic skin treatments are developed. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. |
Detailed competitors of Trigenesis Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Trigenesis Therapeutics (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Trigenesis Therapeutics
Trigenesis Therapeutics was founded in 2003.
Trigenesis Therapeutics is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Trigenesis Therapeutics was established in 2003 in Philadelphia, United States, focusing on the pharmaceutical sector. Products for dermatology applications are created through proprietary drug delivery technology platforms. A pipeline of specialized drugs in the dermatology field is advanced by the firm. Operations emphasize innovation in therapeutic delivery methods. The entity was acquired by Dr. Reddys Laboratories in May 2004.
Trigenesis Therapeutics's top competitors include Revance Therapeutics, Sutro Biopharma and Avidity Biosciences.
Trigenesis Therapeutics has 1 investor. Key investors include Dr. Reddy's Laboratories.
Yes. Trigenesis Therapeutics was acquired by Dr. Reddy's Laboratories in May 2004.